Kite collaborates to increase efficiency of CAR-T manufacture
MaxCyte announces a partnership with Kite to explore the use of flow electroporation technology to enable the non-viral cell engineering of CAR-T drug candidates.
Archives for March 7, 2019
Krystal moves towards ‘full integration’ with gene therapy facility opening
Krystal opens cGMP facility for the clinical and commercial manufacture of its lead drug candidate, KB103, and plans to open its second in 2020.
$4bn collaboration sees Abpro expand its global capabilities
Abpro and NJCTTQ enter $4bn agreement to develop bispecific antibody therapies for immuno-oncology and extend its global reach.